KRAS and non-small cell lung carcinoma: In addition, Roc-A treatment was shown to inhibit proliferation, migration, and anchorage-independent growth in a subset of KRAS-mutated NSCLC cell lines (Yurugi et al, 2017), suggesting mtdsRNA may be an important DAMP.